47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
32.50.Z - Manufacture of medical and dental instruments and supplies
32.99.Z - Other manufacturing notelsewhere classified
46.46.Z - Wholesale of pharmaceutical goods
72.19.Z - Other research and experimental development on natural sciences and engineering
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.23.Z - Dental practice activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,1 | 162,3 | ||
Gross profit (loss) | 0,6 | 0,2 | -0,3 | -255,8 |
EBITDA | 0,7 | 0,5 | -0,1 | -120 |
Short time liabilities | 0,4 | 1,4 | 1,8 | 28,1 |
Other operating costs | 0 | -82,7 | ||
Equity capital | 0,8 | 1,1 | 0,7 | -37,3 |
Operating profit (EBIT) | 0,6 | 0,3 | -0,2 | -172,6 |
Assets | 2,6 | 3,9 | 4,2 | 10,2 |
Net profit (loss) | 0,5 | 0,2 | -0,3 | -269,6 |
Cash | 0 | 0,2 | 0,1 | -24,4 |
Net income from sale | 4,3 | 7,8 | 6,1 | -21,6 |
Liabilities and provisions for liabilities | 1,8 | 2,8 | 3,6 | 28 |
Working assets | 0,7 | 1,7 | 1,9 | 6,4 |
Other income costs | 0,5 | 226,6 | ||
Depreciation | 0,1 | 0,1 | 0,2 | 9,2 |
% | % | % | p.p. | |
Profitability of capital | 68,6 | 38,7 | ||
Equity capital to total assets | 30,8 | 27,3 | 15,6 | -11,7 |
Gross profit margin | 13,7 | 2,6 | -5,2 | -7,8 |
EBITDA Margin | 15,6 | 6,2 | -1,6 | -7,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 38 | -10 | ||
Current financial liquidity indicator | 1.5801335573196411 | 1.2485591173171997 | 1.0364632606506348 | -0,2 |
Net dept to EBITDA | 1.7932485342025757 | -0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane